MiRagen Therapeutics Garners $41,000,000 Series C Funding Round

  • Feed Type
  • Date
    11/10/2015
  • Company Name
    MiRagen Therapeutics
  • Mailing Address
    6200 Lookout Rd. Boulder, CO 80301 USA
  • Company Description
    Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
  • Website
    http://www.miragentherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $41,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    miRagen plans to use the proceeds from the financing to advance two product candidates, MRG-106 and MRG-201, into clinical development this year. Gross proceeds of $41 million included conversion of outstanding notes.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy